TerrAscend (TSNDF) Change in Accured Expenses (2021 - 2024)
TerrAscend (TSNDF) posted quarterly Change in Accured Expenses of $85000.0 for Q4 2024, up 102.35% year-over-year from $42005.7 in Q1 2024, and up 34.92% quarter-over-quarter from $63000.0 in Q3 2024.
TerrAscend (TSNDF) Change in Accured Expenses (2021 - 2024) Analysis & Trends
TerrAscend (TSNDF) has reported Change in Accured Expenses for 4 consecutive years, with $85000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Change in Accured Expenses rose 102.35% year-over-year to $85000.0; the TTM figure through Dec 2024 stood at -$388000.0 (up 81.26% YoY), while the FY2024 annual figure was -$388000.0, up 81.26% from the prior year.
- Change in Accured Expenses grew to $85000.0 in Q4 2024 per TSNDF's latest filing, from $63000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $17.8 million in Q4 2021 and bottomed at -$9.9 million in Q2 2022.
- Historically, Change in Accured Expenses has averaged $117692.3 across 4 years, with a median of -$14000.0 in 2023.
- Annual changes were most pronounced in 2023 — Change in Accured Expenses soared 136.23% — and 2024, when it sank 3735.71%.
- TerrAscend's Change in Accured Expenses stood at $17.8 million in 2021, then slumped by 123.66% to -$4.2 million in 2022, then increased by 14.39% to -$3.6 million in 2023, then soared by 102.35% to $85000.0 in 2024.
- Business Quant data shows TSNDF's Change in Accured Expenses at $85000.0 in Q4 2024, $63000.0 in Q3 2024, and $1000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | TerrAscend | 187.35 Mn | 145.23 Mn | 36.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 85,000.00 |
| Dec 31, 2024 | 85,000.00 |
| Sep 30, 2024 | 63,000.00 |
| Sep 30, 2024 | 63,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | -537,000.00 |
| Mar 31, 2024 | -537,000.00 |
| Dec 31, 2023 | -3.61 Mn |
| Dec 31, 2023 | -3.61 Mn |
| Sep 30, 2023 | 1.72 Mn |
| Sep 30, 2023 | 1.72 Mn |
| Jun 30, 2023 | -159,000.00 |
| Jun 30, 2023 | -159,000.00 |
| Mar 31, 2023 | -14,000.00 |
| Mar 31, 2023 | -14,000.00 |
| Dec 31, 2022 | -4.22 Mn |
| Dec 31, 2022 | -4.22 Mn |
| Sep 30, 2022 | 726,000.00 |
| Sep 30, 2022 | 726,000.00 |